Boehringer-Ingelheim Aug 10, 2020 Real-World Data Reinforces Survival Benefit of Sequential Gilotrif, Tagrisso in EGFR-Mutated NSCLC Aug 6, 2019 Lung Cancer Survival Benefit From Gilotrif, Tagrisso Sequence Therapy Emerges from Real-World Data Jun 6, 2019 TAPUR Study Investigators Report First Positive Findings, Pursuing Tissue-Agnostic Cohorts Premium Jan 18, 2018 Qiagen Gets FDA OK for Expanded Use of EGFR CDx for Lung Cancer Drug Jun 6, 2017 New Precision Oncology Options Emerge at ASCO in First-Line EGFR-Mutated, ALK-Positive Lung Cancer Premium Breaking News Dragonfly Therapeutics Begins Phase II Trial of HER2-Targeted NK-Cell Engager Touchlight to Provide DNA Vector for Odimma Therapeutics' Personalized Neoantigen Vaccine Trial FDA Approves Thermo Fisher HLA Typing Test as CDx for Immunocore Uveal Melanoma Therapy Caris Life Sciences, Hummingbird Bioscience Partner on Anti-HER3 Therapy Advancement Akeso, Summit Therapeutics Ink $5B Licensing Deal for PD-1/VEGF Bispecific Antibody Bluestar Genomics to Study Pancreatic Cancer Early Detection Test in Type 2 Diabetes Patients
